Cano Health (CANO) Misses Q3 EPS by 20c, Revenue Misses

Cano Health (NYSE: CANO) reported Q3 EPS of ($0.23), $0.20 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $665 million versus the consensus estimate of $719.18 million.

For earnings history and earnings-related data on Cano Health (CANO) click here.

You May Also Be Interested In

• Lockheed Martin (LMT) Tops Q1 EPS by 53c, Beats on Revenue; Offers FY24 Guidance
• NextEra Energy (NEE) Tops Q1 EPS by 16c, provides guidance
• Kiniksa Pharmaceuticals, Ltd. (KNSA) Misses Q1 EPS by 11c; raises guidance